VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
Instant Clinical Pharmacology E.J. Begg
First, zero, pseudo-zero order elimination Clearance
PHARMACOKINETIC.
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
VM 8314 Dr. Wilcke Drug Distribution. VM 8314 Dr. Wilcke  Vascular space =  Plasma/plasma water + (extracellular space)  Many RBC’s (intracellular.
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
Week 5- Pharmacokinetics of oral absorption
Week 3 - Biopharmaceutics and Pharmacokinetics
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Week 4 - Biopharmaceutics and Pharmacokinetics
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Karunya Kandimalla, Ph.D. Assistant Professor, Pharmaceutics
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
From A Physiologic Perspective Chemical Clearance from the Body
BASIC PHARMACOKINETIC PARAMETERS. PHARMACOKINETICS Pharmacokinetics is the study of the time course of a drug within the body and incorporates the processes.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
INTRODUCTION CLINICAL PHARMACOKINETICS
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Compartmental Models and Volume of Distribution
Allie punke Pharmacokinetics tutoring Fall 2016
Physiology for Engineers
Allie punke Pharmacokinetics tutoring Fall 2016
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Pharmaceutics 2.
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Hawler Medical University
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Biopharmaceutics Chapter-6
School of Pharmacy, University of Nizwa
1-C: Renal and Hepatic Elimination
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Presentation transcript:

VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)

VM 8314 Dr. Jeff Wilcke  AKA “Apparent volume of distribution”  The volume of fluid that appears to contain the amount of drug in the body  May not be actual physiologic space(s)  Relates amount to plasma concentration  The volume that must be processed by organs of elimination Volume of distribution

VM 8314 Dr. Jeff Wilcke Volume of distribution  Equations  Experimentally:  Vz = Dose / Cp0  Intellectually:  Vz = Amount in the body / Cpt  Units  Liters or milliliters (whole animal or human beings)  Liters/kg or milliliters/kg (typical vet med)

VM 8314 Dr. Jeff Wilcke Volume of distribution 1)Give IV Bolus 2)Take samples over time 3)Cp0 is Y axis interecept 4)You know the dose Vz = Dose / Cp0

VM 8314 Dr. Jeff Wilcke Volume of Distribution ScenarioPhysiologic SpaceVz Drug distributed only to plasma water Blood volume = 7% of body weight Plasma water = 55% of blood volume liters/kg Drug distributed evenly in ECF only Extracellular fluid volume = 25% of body weight 0.25 liters/kg Drug distributed evenly ECF and ICF only. Intracellular fluid volume = 40% of body weight0.65 liters/kg ICF concentration = 3 x’s ECFExtracellular fluid volume + 3x intracellular fluid volume 1.45 liters/kg

VM 8314 Dr. Jeff Wilcke Volume of distribution Much like row 2 or 3 of table Much like row 4 of table

VM 8314 Dr. Jeff Wilcke Clearance  The volume of plasma water cleared of drug during a specified period of time

VM 8314 Dr. Jeff Wilcke Clearance  Organ clearance is:  Efficiency X Flow (fraction of drug removed X organ flow)  Clearance = Q x E  Total clearance is:  The sum of all organ clearances  Cl total =Cl hepatic + Cl renal + Cl pulmonary  Experimentally:  Clearance = V z x λ z

VM 8314 Dr. Jeff Wilcke Clearance  I know it’s weird but:  At a particular concentration, extracting ½ the drug from ALL the flow is the same thing as extracting ALL the drug from ½ the flow  (We “clearance” not “amount removed” because it works int with the samples we take and the math we can do).

VM 8314 Dr. Jeff Wilcke So in one minute… 200 µg/ml (1 ml) 100 µg/ml (1 ml) 0% cleared from 0.5 ml. 100 % cleared from 0.5 ml. Clearance is 0.5 ml/min Passes through liver in 1 minute

VM 8314 Dr. Jeff Wilcke Clearance  Units  Volume / unit time (l/hr, l/min, ml/min, etc.)  Whole animals or human beings  Volume / kilogram / unit time  Animals

VM 8314 Dr. Jeff Wilcke Rate constant of elimination (λz)  The fraction of the volume of distribution cleared per unit time.  The slope of the natural log plot of drug concentration verus time profile.

VM 8314 Dr. Jeff Wilcke Clearing the tank…

VM 8314 Dr. Jeff Wilcke Clearing the tank Concentration vs time points represent concentrations determined for samples taken from the tank.

VM 8314 Dr. Jeff Wilcke Elimination half-life  The time for elimination of one half of the total amount in the body  Equation:  T 1/2 = 0.693/λz (elimination rate constant)  Units:  Time (hours, minutes, seconds…)

VM 8314 Dr. Jeff Wilcke Elimination half life  Utility  Tissue Residues  At 5 x T 1/2 (after you stop dosing) 97% has been eliminated.  Make sure you use the longest half-life  Metabolites MAY be more important than the drug  Absorption may have the longest half-life.

VM 8314 Dr. Jeff Wilcke Elimination half-life  Utility  Approach to “Steady state”  Drugs with long half-lifes “accumulate” during repeated administration  A 5 x T 1/2 concentrations reach 97% of steady state  Digoxin – maximum effects 8 days after therapy starts  Need for loading dose  A loading dose is an initial dose given to shorten the time it takes to reach steady state (“load” the body to steady state amounts and concentrations).

VM 8314 Dr. Jeff Wilcke Steady state

VM 8314 Dr. Jeff Wilcke Absorption rate constant (ka)  Fractional rate at which drug moves from the place the dose was put INTO the circulatory system.  Units  Time (hours, minutes, seconds…)  Application  Combined with elimination rate, determines time to reach peak concentration (C max )

VM 8314 Dr. Jeff Wilcke Fraction of dose absorbed  Other than IV, it is rare that the ENTIRE dose is actually absorbed  Oral  Destroyed, eliminated unchanged  IM  Hydrolyzed in tissue, bound to tissues, stuck in abscess  Units  Percentage or decimal (80% = 0.8)

VM 8314 Dr. Jeff Wilcke Fraction of dose absorbed  Bioavailability Two oral dose forms of the same drug. F of the “open triangle” dose form is ½ the “filled triangle” dose form.

VM 8314 Dr. Jeff Wilcke Fraction of dose aborbed  Bioavailability and Bioequivalence Equal bioavailability (same F) and Bioequivalent Equal bioavailability (same F) and not Bioequivalent